Association between the human papillomavirus, bacterial vaginosis and cervicitis and the detection of abnormalities in cervical smears from teenage girls and young women

Diagnostic Cytopathology

Volumn 43, Issue 10, 2015, Pages 780-785

  Caixeta, Rodrigo Cesar Assis ^a   Ribeiro, Andrea Alves ^a   Segatti, Kelly Deyse ^a   Saddi, Vera Aparecida ^b   Figueiredo Alves, Rosane Ribeiro ^a   Dos Santos Carneiro, Megmar Aparecida ^a   Rabelo Santos, Silvia Helena ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

Author keywords

adolescent girls; bacterial vaginosis; cervicitis; HPV; young adults

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; VAGINITIS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR; VAGINOSIS, BACTERIAL; VIROLOGY; YOUNG ADULT;

VIRUS DNA;

ADOLESCENT; ADULT; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; DNA, VIRAL; FEMALE; HUMANS; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICITIS; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84941247936     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23301     Document Type: Article

References (36)

1. Zandberg DP, Bhargava R, Badin S, Cullen KJ., The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 2012; 63: 57-81.
2. Sasagawa T, Takagi H, Makinoda S., Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother 2012; 18: 807-815.
3. Snijders PJF, Steenbergen RDM, Heideman DAM, Meijer CJLM., HPV-mediated cervical carcinogenesis: Concepts and clinical implications. J Pathol 2006; 208: 152-164.
4. Guo Y-I, You K, Qiao J, et al., Bacterial vaginosis is conducive to the persistence of HPV infection. Int J STD AIDS 2012; 23: 581-584.
5. Figueiredo PG, Sarian LO, Tambascia JK, et al., Increased detection of clue cells in smears from cervical intraephitelial lesions with reduced expression of COX-2. Diagn Cytopathol 2008; 36: 705-709.
6. Shipitsyna E, Roos A, Datcu R, et al., Composition of the vaginal microbiota in women of reproductive age-Sensitive and specific molecular diagnosis of bacterial vaginosis is possible? Plos One 2013; 08: 10.
7. Brenna SMF, Hardy E, Zeferino LC, Namura I., Knowledge, attitudes, and practices related to the Pap smear among women with cervical cancer. Cad Saude Pub 2001; 17: 909-914.
8. Srinivasan S, Liu C, Mitchell CM, et al., Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. Plos One 2010; 05: 8.
9. Gelber SE, Aguilar JL, Lewis KLT, Ratner AJ., Functional and phylogenetic characterization of vaginolysin, the human-specific cytolisin from Gardnerella vaginalis. J Bacteriol 2008; 190: 3896-3903.
10. Marconi C, Donders GGG, Bellen G, et al., Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 2013; 167: 205-209.
11. Castle PE, Hillier SL, Rabe LK, et al., An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10: 1021-1027.
12. Sales KJ, Katz AA., Inflammatory pathways in cervical cancer-The UCT contribution. S Afr Med J 2012; 102: 493-496.
13. Barouti E, Farzaneh F, Sene AA, et al., The pathogenic microorganisms in papanicolaou vaginal smears and correlation with inflammation. JFRH 2013; 07: 23-27.
14. Adefuye A, Sales K., Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica 2012; 2012: 8.
15. Solomon D, Nayar R., The Bethesda system for reporting cervical cytology: Definitions, criteria, and explanatory notes. USA: Springer-Verlag; 2005.
16. Discacciati MG, Simoes JA, Amaral RG, et al., Presence of 20% or more clue cells: An accurate criterion for the diagnosis of bacterial vaginosis in Papanicolaou cervical smears. Diagn Cytopathol 2006; 34: 272-276.
17. Gillet E, Meys JFA, Verstraelen H, et al., Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis. Plos One 2012; 07: 10.
18. Carvalho VCV, Macêdo JL, Lima CAD, et al., IFN-gamma and IL-12B polymorphisms in women with cervical intraepithelial neoplasia caused by human Papillomavirus. Mol Biol Rep 2012; 39: 7627-7634.
19. Delves PJ, Roitt IM., The immune system. First of two parts. N Engl J Med 2000; 343: 37-49.
20. Murta EFC, Souza MAH, Júnior EA, Adad SJ., Incidence of Gardnerella vaginalis, Candida sp and human papilloma virus in cytological smears. Sao Paulo Med J 2000; 118: 105-108.
21. Feng Q, Wei H, Morihara J, et al., Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol 2012; 127: 412-419.
22. Livengood CH., Bacterial vaginosis: An overview for 2009. Rev Obstet Gynecol 2009; 02: 28-37.
23. Grivennikov SI, Greten FR, Karin M., Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
24. Samoff E, Koumans EH, Markowitz LE, et al., Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162: 668-675.
25. Bruni L, Castellsagué X, Ferrer E, et al., Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-1799.
26. Alves RRF, Turchi MD, Santos LD, et al., Prevalence, genotype profile and risk factors for multiple human papillomavirus cervical infection in unimmunized female adolescents in Goiânia, Brazil: A community-based study. BMC Public Health 2013; 13: 1041-1053.
27. Shin HR, Franceschi S, Vaccarella S, et al., Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004; 190: 468-476.
28. Papachristou E, Sypsa V, Paraskevis D, et al., Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test. J Med Virol 2009; 81: 2059-2065.
29. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G., Inflammation and cancer: How hot is the link? Biochem Pharmacol 2006; 72: 1605-1621.
30. Schmauz R, Okong P, de Villiers EM, et al., Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 1989; 43: 805-809.
31. Hopman A, Theelen W, Hommelberg P, et al., Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 2006; 210: 412-419.
32. Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ., HPV-DNA integration and carcinogenesis: Putative roles for inflammation and oxidative stress. Future Virol 2011; 6: 45-57.
33. Arbyn M, Sasieni P, Meijer CJLM, et al., Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine 2006; 24: S3/78-89.
34. Schiffman M., Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 2007; 111: 145-153.
35. Moscicki AB., HPV vaccines: Today and in the future. J Adolesc Health 2008; 43: S26-S40.
36. Hager WD., Human papilloma virus infection and prevention in the adolescent population. J Pediatr Adolesc Gynecol 2009; 22: 197-204.